Saluda Medical Inc
Saluda Medical, Inc., a medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands. The company develops a closed-loop spinal cord stimulation system that measures the spinal cord's response to stimulation and adjusts on every pulse to optimize activation within the patient's therapeut… Read more
Market Cap & Net Worth: Saluda Medical Inc (SLD)
Saluda Medical Inc (AU:SLD) has a market capitalization of $4.92K (AU$7.95K) as of March 19, 2026. Listed on the AU stock exchange, this Australia-based company holds position #38540 globally and #1456 in its home market, demonstrating a -17.73% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Saluda Medical Inc's stock price AU$0.84 by its total outstanding shares 9517 (9.52K).
Saluda Medical Inc Market Cap History: 2025 to 2026
Saluda Medical Inc's market capitalization history from 2025 to 2026. Data shows growth from $8.40K to $4.92K (0.00% CAGR).
Saluda Medical Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Saluda Medical Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of SLD by Market Capitalization
Companies near Saluda Medical Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Saluda Medical Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Saluda Medical Inc Historical Marketcap From 2025 to 2026
Between 2025 and today, Saluda Medical Inc's market cap moved from $8.40K to $ 4.92K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$4.92K | -41.40% |
| 2025 | AU$8.40K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Saluda Medical Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.92K USD |
| MoneyControl | $4.92K USD |
| MarketWatch | $4.92K USD |
| marketcap.company | $4.92K USD |
| Reuters | $4.92K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.